http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-054849-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
filingDate 2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-054849-A1
titleOfInvention DIAZEPINOQUINOLINAS, SYNTHESIS OF THE SAME, AND INTERMEDIARIES TO OBTAIN THEM
abstract It refers to methods for synthesizing useful compounds such as 5HT2c agonists or partial agonists, derivatives thereof, and intermediates to obtain them. Claim 1: A method of preparing a compound of formula (2) or a pharmaceutically acceptable salt thereof, wherein: n is 0, 1 or 2; R1 and R2 are each independently halogen, -CN, phenyl, -R, -OR, --C 1-6 perfluoroalkyl, or -O-C 1-6 perfluoroalkyl; each R is independently H or C1-6 alkyl; and R7 is H or C1-6 alkyl, which comprises the steps of: (a) providing a compound of formula E where R1 and R2 are each independently halogen, -CN, phenyl, -R, -OR, -C1 -perfluoroalkyl 6, or -O-C1-6 perfluoroalkyl; and each R is independently H or C1-6 alkyl; (b) treating said compound of formula E with a chiral agent to form a compound of formula D-1; where R1 and R2 are each independently halogen, -CN, phenyl, -R, -OR, -C 1-6 perfluoroalkyl, or -O-C 1-6 perfluoroalkyl; each R is independently H or C1-6 alkyl; and X is a chiral agent; (c) obtain a compound of formula D by suitable physical means; where R1 and R2 are each independently halogen, -CN, phenyl, -R, -OR, -C 1-6 perfluoroalkyl, or -O- C 1-6 perfluoroalkyl; each R is independently H or C1-6 alkyl; and X is a chiral agent; (d) treating said compound of formula D with a suitable base to provide a compound of formula C; where R1 and R2 are each independently halogen, -CN, phenyl, -R, -OR, -C 1-6 perfluoroalkyl, or -O-C 1-6 perfluoroalkyl; and each R is independently H or C1-6 alkyl; (e) renting said compound of formula C to form a compound of formula B, where n is 0, 1, or 2; R1 and R2 are each independently halogen, -CN, phenyl, -R, -OR, -C 1-6 perfluoroalkyl, or -O-C 1-6 perfluoroalkyl; each R is independently H or C1-6 alkyl; and PG2 is a suitable amino protecting group; (f) deprotecting said compound of formula B to form a compound of formula A, where n is 0, 1, or 2; R1 and R2 are each independently halogen, -CN, phenyl, -R, -OR, -C 1-6 perfluoroalkyl, or -O-C 1-6 perfluoroalkyl; and each R is independently H or C1-6 alkyl; and (g) reacting said compound of formula A with formaldehyde, or unequivalent thereof, to form a compound of formula (2).
priorityDate 2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712

Total number of triples: 31.